CXCR4 and osteosarcoma: Previous experimental studies showed that SIN exerts its anticancer effect in prostate cell carcinoma and human osteosarcoma cells via inactivating JAK/STAT and CXCR-4-STAT3 signaling pathways (Xie et al., 2016; Xu et al., 2019).